Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by CrazyFrog2on Oct 13, 2018 12:23am
61 Views
Post# 28793535

RE:Strips...To be or not to be

RE:Strips...To be or not to beSo says you.   LDS has been saying the opposite for the past 3 years.  So what is it ? You making up excuses or LDS hasn’t a clue ? ......
Hempdoc wrote: Trying to precisely distill LDS’ trajectory may be more a foolhardy task than a monumental one...too many unknowns, too little revenue data...just trying to keep my eye on the next curve ball.

1). Staying on the lookout for LDS converting their enhanced provisional patent by year end.  It was in early Jan of this year they announced they had submitted an enhanced provisional app.  LDS will have to file a “non-provisional” app by early Jan 2019 in order to claim the Jan 2018 filing date as the date of invention.  This date would thus serve as the starting date for any patent rights protection, if granted.  Once the non-provisional app is filed, it can be tracked through the USPTO...unlike the provisional, which is not published.

2). Are the CannaStrips an illusion?   These unseen precious strips have been studied, enhanced, re-enhanced, packaged, repackaged....If they exist & are unique/patentable as reported, it is no surprise they would not be on shelves at this time.   Any public use or sales of this “enhanced version” strip can constitute prior art & invalidate your future patent.  If patentability is important to LDS, & it should be if they want to maximize future profits/licensing opportunities, I do not expect to see the strips on shelves until the non-provisional app has been filed.

3). Clinical trials?  I also do not see this happening until a non-provisional app is filed, which would also help mitigate any future potential for litigation, etc.

4). Keeping $1 million monthly revenue as my low-end threshold (til year end) based on projected cash burn rates in the near term.

Good Luck Longs




Bullboard Posts